Safety efforts in pediatric drug development:
Saved in:
| Format: | Electronic eBook |
|---|---|
| Language: | English |
| Published: |
New York
Nova Science Publishers
c2010
|
| Series: | Pharmacology-research, safety testing, and regulation series
|
| Subjects: | |
| Online Access: | FAW01 FAW02 Volltext |
| Item Description: | Includes bibliographical references and index FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO. |
| Physical Description: | 1 Online-Ressource (xiv, 133 p.) |
| ISBN: | 1607415658 161209368X 9781607415657 9781612093680 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043164615 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 1607415658 |9 1-60741-565-8 | ||
| 020 | |a 161209368X |c electronic bk. |9 1-61209-368-X | ||
| 020 | |a 9781607415657 |9 978-1-60741-565-7 | ||
| 020 | |a 9781612093680 |c electronic bk. |9 978-1-61209-368-0 | ||
| 035 | |a (OCoLC)699510130 | ||
| 035 | |a (DE-599)BVBBV043164615 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 615/.190083 |2 22 | |
| 245 | 1 | 0 | |a Safety efforts in pediatric drug development |c Conor D. Byrne, editor |
| 264 | 1 | |a New York |b Nova Science Publishers |c c2010 | |
| 300 | |a 1 Online-Ressource (xiv, 133 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Pharmacology-research, safety testing, and regulation series | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO. | ||
| 610 | 1 | 4 | |a United States |
| 610 | 2 | 4 | |a United States |t Best Pharmaceuticals for Children Act |
| 650 | 7 | |a MEDICAL / Drug Guides |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Pharmacy |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Nursing / Pharmacology |2 bisacsh | |
| 650 | 4 | |a Drug Approval / United States | |
| 650 | 4 | |a Child / United States | |
| 650 | 4 | |a Drug Evaluation / standards / United States | |
| 650 | 4 | |a Drug Toxicity / prevention & control / United States | |
| 650 | 4 | |a Legislation, Drug / United States | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Pediatric pharmacology |z United States | |
| 650 | 4 | |a Pediatrics |z United States |v Formulae, receipts, prescriptions |x Safety measures | |
| 650 | 4 | |a Drug development |z United States |x Safety measures | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Byrne, Conor D. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=349633 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028588806 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=349633 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=349633 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Record in the Search Index
| _version_ | 1804175638352887808 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043164615 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)699510130 (DE-599)BVBBV043164615 |
| dewey-full | 615/.190083 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.190083 |
| dewey-search | 615/.190083 |
| dewey-sort | 3615 6190083 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02938nmm a2200577zc 4500</leader><controlfield tag="001">BV043164615</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1607415658</subfield><subfield code="9">1-60741-565-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">161209368X</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-61209-368-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781607415657</subfield><subfield code="9">978-1-60741-565-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781612093680</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-61209-368-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)699510130</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043164615</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.190083</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Safety efforts in pediatric drug development</subfield><subfield code="c">Conor D. Byrne, editor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Science Publishers</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiv, 133 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacology-research, safety testing, and regulation series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO.</subfield></datafield><datafield tag="610" ind1="1" ind2="4"><subfield code="a">United States</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">United States</subfield><subfield code="t">Best Pharmaceuticals for Children Act</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Drug Guides</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Nursing / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Child / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation / standards / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Toxicity / prevention & control / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pediatric pharmacology</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pediatrics</subfield><subfield code="z">United States</subfield><subfield code="v">Formulae, receipts, prescriptions</subfield><subfield code="x">Safety measures</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield><subfield code="z">United States</subfield><subfield code="x">Safety measures</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Byrne, Conor D.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=349633</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028588806</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=349633</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=349633</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043164615 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:28Z |
| institution | BVB |
| isbn | 1607415658 161209368X 9781607415657 9781612093680 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028588806 |
| oclc_num | 699510130 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xiv, 133 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Nova Science Publishers |
| record_format | marc |
| series2 | Pharmacology-research, safety testing, and regulation series |
| spelling | Safety efforts in pediatric drug development Conor D. Byrne, editor New York Nova Science Publishers c2010 1 Online-Ressource (xiv, 133 p.) txt rdacontent c rdamedia cr rdacarrier Pharmacology-research, safety testing, and regulation series Includes bibliographical references and index FDA's authority to ensure that drugs prescribed to children are safe and effective / Susan Thaul -- Guidance for industry nonclinical safety evaluation of pediatric drug products / U.S. Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER) -- Pediatric drug research : studies conducted under Best Pharmaceuticals for Children Act / GAO -- Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act / GAO. United States United States Best Pharmaceuticals for Children Act MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug Approval / United States Child / United States Drug Evaluation / standards / United States Drug Toxicity / prevention & control / United States Legislation, Drug / United States Medizin Pediatric pharmacology United States Pediatrics United States Formulae, receipts, prescriptions Safety measures Drug development United States Safety measures USA Byrne, Conor D. Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=349633 Aggregator Volltext |
| spellingShingle | Safety efforts in pediatric drug development United States United States Best Pharmaceuticals for Children Act MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug Approval / United States Child / United States Drug Evaluation / standards / United States Drug Toxicity / prevention & control / United States Legislation, Drug / United States Medizin Pediatric pharmacology United States Pediatrics United States Formulae, receipts, prescriptions Safety measures Drug development United States Safety measures |
| title | Safety efforts in pediatric drug development |
| title_auth | Safety efforts in pediatric drug development |
| title_exact_search | Safety efforts in pediatric drug development |
| title_full | Safety efforts in pediatric drug development Conor D. Byrne, editor |
| title_fullStr | Safety efforts in pediatric drug development Conor D. Byrne, editor |
| title_full_unstemmed | Safety efforts in pediatric drug development Conor D. Byrne, editor |
| title_short | Safety efforts in pediatric drug development |
| title_sort | safety efforts in pediatric drug development |
| topic | United States United States Best Pharmaceuticals for Children Act MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug Approval / United States Child / United States Drug Evaluation / standards / United States Drug Toxicity / prevention & control / United States Legislation, Drug / United States Medizin Pediatric pharmacology United States Pediatrics United States Formulae, receipts, prescriptions Safety measures Drug development United States Safety measures |
| topic_facet | United States United States Best Pharmaceuticals for Children Act MEDICAL / Drug Guides MEDICAL / Pharmacology MEDICAL / Pharmacy MEDICAL / Nursing / Pharmacology Drug Approval / United States Child / United States Drug Evaluation / standards / United States Drug Toxicity / prevention & control / United States Legislation, Drug / United States Medizin Pediatric pharmacology United States Pediatrics United States Formulae, receipts, prescriptions Safety measures Drug development United States Safety measures USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=349633 |
| work_keys_str_mv | AT byrneconord safetyeffortsinpediatricdrugdevelopment |